Cary Street Partners Investment Advisory’s ResMed RMD Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$267K	Sell	1,369 -12	-0.9%	-$2.49K	0.05%	317
2026 Q1	$310K	Buy	1,381 +486	+54%	+$121K	0.08%	272
2025 Q4	$216K	Sell	895 -6	-0.7%	-$1.53K	0.06%	311
2025 Q3	$247K	Sell	901 -139	-13%	-$38K	0.1%	223
2025 Q2	$268K	Buy	1,040 +20	+2%	+$4.77K	0.13%	176
2025 Q1	$228K	Sell	1,020 -165	-14%	-$38.5K	0.13%	189
2024 Q4	$271K	Sell	1,185 -36	-3%	-$8.67K	0.18%	132
2024 Q3	$298K	Buy	1,221 +17	+1%	+$3.8K	0.01%	626
2024 Q2	$231K	Sell	1,204 -3	-0.2%	-$609	0.01%	670
2024 Q1	$239K	Sell	1,207 -70	-5%	-$12.8K	0.01%	614
2023 Q4	$220K	Buy	1,277 +1,120	+713%	+$172K	0.01%	596
2023 Q3	$23.2K	Buy	157 +127	+423%	+$23K	﹤0.01%	1069
2023 Q2	$6.55K	Buy	+30	New	+$6.69K	﹤0.01%	1341

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Cary Street Partners Investment Advisory's RMD Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its ResMed (RMD) stake by 0.87% in Q2 2026, selling an estimated $2.49K and leaving 1,369 shares worth $267K. The position accounts for 0.05% of the portfolio, ranked #317.

Cary Street Partners Investment Advisory first reported a position in RMD in Q2 2023 and has held it in 13 quarters since. The position peaked at $310K in Q1 2026. 562 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Cary Street Partners Investment Advisory held 1,369 shares of ResMed worth $267K as of Q2 2026.
Cary Street Partners Investment Advisory sold 12 ResMed shares in Q2 2026, an estimated $2.49K.
ResMed made up 0.05% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #317 holding.
Cary Street Partners Investment Advisory first reported a position in ResMed in Q2 2023 and has held it in 13 quarters since.
Cary Street Partners Investment Advisory's ResMed position peaked at $310K in Q1 2026.
562 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.